☆ 4.8 Article

Quantitative Spatial Profiling of Immune Populations in Pancreatic Ductal Adenocarcinoma Reveals Tumor Microenvironment Heterogeneity and Prognostic Biomarkers

CANCER RESEARCH (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Immunology

Multi-Scale Spatial Analysis of the Tumor Microenvironment Reveals Features of Cabozantinib and Nivolumab Efficacy in Hepatocellular Carcinoma

Haoyang Mi et al.

Summary: This study used fluorescent cell mapping technology to analyze the tumor microenvironment in patients with HCC, and found that the expression patterns of PD-L1 and Granzyme B were different in different regions. The close contact between CD8(+) T cells and Arg1(hi) macrophages was a prominent feature in non-responders. In addition, cell community analysis found that the communication between macrophage-enriched cell communities and lymphocyte-enriched cell communities with tumor cell communities was stronger in non-responders.

FRONTIERS IN IMMUNOLOGY (2022)

添加到收藏夹

Article Biochemical Research Methods

Simulations of tumor growth and response to immunotherapy by coupling a spatial agentbased model with a whole-patient quantitative systems pharmacology model

Alvaro Ruiz-Martinez et al.

Summary: This study extends the spatial QSP model to analyze tumor growth dynamics and immune therapy response, which functions as a coarse-grained model at the whole-tumor scale and an agent-based model at the regions of interest scale. The model characterizes tumor growth, identifies T cell hotspots, and performs qualitative and quantitative descriptions of cell density at the invasive front of the tumor.

PLOS COMPUTATIONAL BIOLOGY (2022)

添加到收藏夹

Article Oncology

Cell graph neural networks enable the precise prediction of patient survival in gastric cancer

Yanan Wang et al.

Summary: This study proposes an AI-powered digital staging system that analyzes spatial patterns in the tumor microenvironment to accurately predict survival rates and staging of gastric cancer patients. The results show outstanding model performance and significant improvement over traditional staging systems.

NPJ PRECISION ONCOLOGY (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Dynamics of tumor-associated macrophages in a quantitative systems pharmacology model of immunotherapy in triple-negative breast cancer

Hanwen Wang et al.

Summary: Quantitative systems pharmacology (QSP) modeling is an emerging computational approach that combines drug kinetics/dynamics and disease progression. It has shown importance in drug development, particularly in complex cases such as TNBC. Incorporating the dynamics of tumor-associated macrophages (TAMs) into the QSP model can help understand their impact on cancer treatment. Despite its complexity, the modularized QSP platform is reproducible and applicable for clinical trial simulation.

ISCIENCE (2022)

添加到收藏夹

Review Oncology

Translational advances in pancreatic ductal adenocarcinoma therapy

Abdel Nasser Hosein et al.

Summary: Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer that is often diagnosed at advanced stages, leading to limited treatment options. Recent advancements in targeted therapy and immunotherapy for different subtypes of PDAC are reviewed in this article, with a focus on the current preclinical and clinical evidence supporting these approaches and the potential of combination treatments.

NATURE CANCER (2022)

添加到收藏夹

Article Oncology

Composition, Spatial Characteristics, and Prognostic Significance of Myeloid Cell Infiltration in Pancreatic Cancer

Sara A. Vayrynen et al.

Summary: The study revealed a diverse set of myeloid cells within the PDAC tumor microenvironment, which are distributed heterogeneously across patient tumors. Beyond cell density, the spatial locations of immune cells are also associated with patient outcomes, underscoring the potential role of spatially resolved myeloid cell subtypes as quantitative biomarkers for PDAC prognosis and therapy.

CLINICAL CANCER RESEARCH (2021)

添加到收藏夹

Editorial Material Gastroenterology & Hepatology

The war against pancreatic cancer in 2020-advances on all fronts

Tejeshwar Jain et al.

Summary: In 2020, significant progress was made in three major areas of pancreatic ductal adenocarcinoma (PDAC) research: risk factors, therapeutic resistance, and tumor recurrence. The pathophysiology of obesity-mediated PDAC initiation was elucidated, novel stromal mechanisms of therapeutic resistance were unveiled, and the genetic evolution of recurrent PDAC under therapeutic pressures was tracked in human samples.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)

添加到收藏夹

Review Gastroenterology & Hepatology

Understanding the immune response and the current landscape of immunotherapy in pancreatic cancer

Lorena Ostios-Garcia et al.

Summary: Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive tumor with unique microenvironment characteristics and complex immune escape mechanisms. Immunotherapy has not been very successful in treating PDAC, except for a subset of patients with specific genetic mutations who have shown prolonged survival rates.

WORLD JOURNAL OF GASTROENTEROLOGY (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Immune cell topography predicts response to PD-1 blockade in cutaneous T cell lymphoma

Darci Phillips et al.

Summary: This study reveals a spatial biomarker that utilizes immune and cancer cell topography to predict response to PD-1 blockade in cutaneous T cell lymphomas. The biomarker is strongly correlated with the functional immune state of the tumor microenvironment, T cell function, and tumor cell-specific chemokine recruitment.

NATURE COMMUNICATIONS (2021)

添加到收藏夹

Article Oncology

Quantitative systems pharmacology model predictions for efficacy of atezolizumab and nab-paclitaxel in triple-negative breast cancer

Hanwen Wang et al.

Summary: This study introduces a modular quantitative systems pharmacology (QSP) platform for predicting immunotherapy efficacy and identifying predictive biomarkers. Virtual clinical trials were conducted using a virtual patient cohort generated by the model, with retrospective analysis and model validation based on clinical trial data.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

添加到收藏夹

Review Oncology

The Heterogeneity of the Tumor Microenvironment as Essential Determinant of Development, Progression and Therapy Response of Pancreatic Cancer

Anna Maxi Wandmacher et al.

Summary: Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest tumors commonly diagnosed at advanced stages, characterized by tumor heterogeneity at multiple levels. This tumor heterogeneity, along with the impact of the tumor microenvironment and altered microbiome of PDAC patients, plays diverse effects on the development, progression, and therapy responses of PDAC. Understanding and considering this multi-level heterogeneity is crucial for developing novel therapeutic concepts to potentially improve the situation of PDAC patients.

CANCERS (2021)

添加到收藏夹

Article Oncology

Leukocyte Heterogeneity in Pancreatic Ductal Adenocarcinoma: Phenotypic and Spatial Features Associated with Clinical Outcome

Shannon M. Liudahl et al.

Summary: Researchers have established an immune atlas of PDAC through single-cell resolution profiling, identifying leukocyte features correlated with clinical outcomes, which can serve as a valuable reference for PDAC treatment. The data can aid in deeper understanding of the PDAC immune ecosystem, identifying additional therapeutic targets, and providing predictive biomarkers for therapeutic response and resistance monitoring.

CANCER DISCOVERY (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Analysis of multispectral imaging with the AstroPath platform informs efficacy of PD-1 blockade

Sneha Berry et al.

Summary: A comprehensive platform for multispectral imaging and mapping of multiple parameters in tumor tissue sections was introduced, allowing high-fidelity single-cell analysis. This platform identified key features in pretreatment melanoma specimens that predicted response to anti-PD-1 therapy, and stratified long-term survival after anti-PD-1 blockade. The signature was validated in an independent cohort of melanoma patients from a different institution.

SCIENCE (2021)

添加到收藏夹

Article Oncology

A Spatial Quantitative Systems Pharmacology Platform spQSP-IO for Simulations of Tumor-Immune Interactions and Effects of Checkpoint Inhibitor Immunotherapy

Chang Gong et al.

Summary: The study aims to develop a platform that combines the strengths of QSP and ABM models to create a cancer development model in the context of anti-cancer immunity and immune checkpoint inhibition therapy, which can be applied in virtual clinical trials and biomarker discovery.

CANCERS (2021)

添加到收藏夹

Article Cell Biology

Single-cell analysis of pancreatic ductal adenocarcinoma identifies a novel fibroblast subtype associated with poor prognosis but better immunotherapy response

Yu Wang et al.

Summary: The study investigated the heterogeneity among PDAC patients in terms of CAFs, ductal cancer cells, and immune cells, revealing differences between dense-type and loose-type PDAC. A novel subtype of CAFs, meCAFs, was discovered in loose-type PDAC, playing a critical role in disease progression and response to immunotherapy. This finding highlights the importance of considering intertumoral heterogeneity in PDAC treatment strategies.

CELL DISCOVERY (2021)

添加到收藏夹

Article Cell Biology

Predictive models of response to neoadjuvant chemotherapy in muscle-invasive bladder cancer using nuclear morphology and tissue architecture

Haoyang Mi et al.

Summary: A machine-learning framework was developed to predict the response to neoadjuvant chemotherapy in muscle-invasive bladder cancer using imaging of biopsy pathology specimens, achieving promising results through cross-validation and an independent validation cohort. One model was able to stratify the cohort into likely responders based on features derived from stained tissues and clinico-demographic features.

CELL REPORTS MEDICINE (2021)

添加到收藏夹

Article Oncology

Germinal center reactions in tertiary lymphoid structures associate with neoantigen burden, humoral immunity and long-term survivorship in pancreatic cancer

Andrew J. Gunderson et al.

Summary: PDAC tumors show T cell inflamed phenotypes, with some tumors having early-stage TLS which correlates with higher survival rates.

ONCOIMMUNOLOGY (2021)

添加到收藏夹

Article Oncology

Cancer statistics, 2020

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2020)

添加到收藏夹

Article Oncology

Topological Tumor Graphs: A Graph-Based Spatial Model to Infer Stromal Recruitment for Immunosuppression in Melanoma Histology

Henrik Failmezger et al.

CANCER RESEARCH (2020)

添加到收藏夹

Article Multidisciplinary Sciences

The single-cell pathology landscape of breast cancer

Hartland W. Jackson et al.

NATURE (2020)

添加到收藏夹

Article Immunology

Deciphering the Crosstalk Between Myeloid-Derived Suppressor Cells and Regulatory T Cells in Pancreatic Ductal Adenocarcinoma

Carole Siret et al.

FRONTIERS IN IMMUNOLOGY (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial

Bruno Bockorny et al.

NATURE MEDICINE (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Coordinated Cellular Neighborhoods Orchestrate Antitumoral Immunity at the Colorectal Cancer Invasive Front

Christian M. Schurch et al.

CELL (2020)

添加到收藏夹

Article Medicine, General & Internal

Pancreatic cancer

Jonathan D Mizrahi et al.

LANCET (2020)

添加到收藏夹

Article Physiology

Digital Pathology Analysis Quantifies Spatial Heterogeneity of CD3, CD4, CD8, CD20, and FoxP3 Immune Markers in Triple-Negative Breast Cancer

Haoyang Mi et al.

FRONTIERS IN PHYSIOLOGY (2020)

添加到收藏夹

Article Oncology

Combination therapy with T cell engager and PD-L1 blockade enhances the antitumor potency of T cells as predicted by a QSP model

Huilin Ma et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)

添加到收藏夹

Article Oncology

Insights into Tumor-Associated Tertiary Lymphoid Structures: Novel Targets for Antitumor Immunity and Cancer Immunotherapy

Anthony B. Rodriguez et al.

CANCER IMMUNOLOGY RESEARCH (2020)

添加到收藏夹

Article Pharmacology & Pharmacy

QSP-IO: A Quantitative Systems Pharmacology Toolbox for Mechanistic Multiscale Modeling for Immuno-Oncology Applications

Richard J. Sove et al.

CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2020)

添加到收藏夹

Review Oncology

Tumour microenvironment of pancreatic cancer: immune landscape is dictated by molecular and histopathological features

Eva Karamitopoulou

BRITISH JOURNAL OF CANCER (2019)

添加到收藏夹

Review Oncology

Current Status of Immunotherapies for Treating Pancreatic Cancer

Annie A. Wu et al.

CURRENT ONCOLOGY REPORTS (2019)

添加到收藏夹

Article Oncology

Quantitative Characterization of CD8+ T Cell Clustering and Spatial Heterogeneity in Solid Tumors

Chang Gong et al.

FRONTIERS IN ONCOLOGY (2019)

添加到收藏夹

Review Oncology

CAF Subpopulations: A New Reservoir of Stromal Targets in Pancreatic Cancer

Brooke A. Pereira et al.

TRENDS IN CANCER (2019)

添加到收藏夹

Article Immunology

Interleukin-10 Directly Inhibits CD8+ T Cell Function by Enhancing N-Glycan Branching to Decrease Antigen Sensitivity

Logan K. Smith et al.

IMMUNITY (2018)

添加到收藏夹

Review Biochemistry & Molecular Biology

Understanding the tumor immune microenvironment (TIME) for effective therapy

Mikhail Binnewies et al.

NATURE MEDICINE (2018)

添加到收藏夹

Article Biochemistry & Molecular Biology

A Structured Tumor-Immune Microenvironment in Triple Negative Breast Cancer Revealed by Multiplexed Ion Beam Imaging

Leeat Keren et al.

CELL (2018)

添加到收藏夹

Article Oncology

Multidimensional, quantitative assessment of PD-1/PD-L1 expression in patients with Merkel cell carcinoma and association with response to pembrolizumab

Nicolas A. Giraldo et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)

添加到收藏夹

Article Multidisciplinary Sciences

Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer

Julienne L. Carstens et al.

NATURE COMMUNICATIONS (2017)

添加到收藏夹

Article Oncology

Spatial distribution of B cells predicts prognosis in human pancreatic adenocarcinoma

Giovanni Francesco Castino et al.

ONCOIMMUNOLOGY (2016)

添加到收藏夹

Article Medicine, General & Internal

Pancreatic cancer

Jorg Kleeff et al.

NATURE REVIEWS DISEASE PRIMERS (2016)

添加到收藏夹

Editorial Material Gastroenterology & Hepatology

Short-term and long-term risk factors in gastric cancer

Giuseppe Verlato et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2015)

添加到收藏夹

Article Oncology

IL-10 enhances CTL-mediated tumor rejection by inhibiting highly suppressive CD4+ T cells and promoting CTL persistence in a murine model of plasmacytoma

Lixin Wang et al.

ONCOIMMUNOLOGY (2015)

添加到收藏夹

Article Oncology

Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States

Lola Rahib et al.

CANCER RESEARCH (2014)

添加到收藏夹

Article Oncology

Immunotherapy Converts Nonimmunogenic Pancreatic Tumors into Immunogenic Foci of Immune Regulation

Eric R. Lutz et al.

CANCER IMMUNOLOGY RESEARCH (2014)

添加到收藏夹

Review Oncology

Recent progress in pancreatic cancer

Christopher L. Wolfgang et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2013)

添加到收藏夹

Article Oncology

Adjuvant treatment of pancreatic cancer

John P. Neoptolemos

EUROPEAN JOURNAL OF CANCER (2011)

添加到收藏夹

Review Immunology

Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm

Subhra K. Biswas et al.

NATURE IMMUNOLOGY (2010)

添加到收藏夹

Review Immunology

PD-1 and its ligands in tolerance and immunity

Mary E. Keir et al.

ANNUAL REVIEW OF IMMUNOLOGY (2008)

添加到收藏夹

Article Immunology

Pathogen-specific CD8 T cell responses are directly inhibited by IL-10

Partha Sarathi Biswas et al.

JOURNAL OF IMMUNOLOGY (2007)

添加到收藏夹

Article Immunology

IFN-γ suppresses IL-10 production and synergizes with TLR2 by regulating GSK3 and CREB/AP-1 proteins

Xiaoyu Hu et al.

IMMUNITY (2006)

添加到收藏夹

Article Computer Science, Interdisciplinary Applications

spatstat: An R package for analyzing spatial point patterns

A Baddeley et al.

JOURNAL OF STATISTICAL SOFTWARE (2005)

添加到收藏夹

Article Immunology

Reprogramming of IL-10 activity and signaling by IFN-γ1

C Herrero et al.

JOURNAL OF IMMUNOLOGY (2003)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.